Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

The combined company will have a huge stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies and Kleenex tissues…

  • Delta_V@lemmy.worldOP
    link
    fedilink
    English
    arrow-up
    51
    ·
    3 days ago

    The purchase price was historically low due to the libelous accusations of acetaminophen causing autism.

    Investing in corruption pays off bigly when Republicans manage to ooze their way into office.